TSE Fundamental Analysis - TRINSEO PLC

Fundamental Rating

Taking everything into account, TSE scores 2 out of 10 in our fundamental rating. TSE was compared to 84 industry peers in the Chemicals industry. TSE may be in some trouble as it scores bad on both profitability and health. TSE is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

TSE had negative earnings in the past year.

In the past year TSE has reported a negative cash flow from operations.

The reported net income has been mixed in the past 5 years: TSE reported negative net income in multiple years.

TSE had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of -13.26%, TSE is not doing good in the industry: 76.19% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-13.26%
ROE	N/A
ROIC	N/A

ROA(3y)-15.93%

ROA(5y)-7.64%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

TSE's Operating Margin has declined in the last couple of years.

TSE has a worse Gross Margin (7.92%) than 85.71% of its industry peers.

In the last couple of years the Gross Margin of TSE has declined.

TSE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	7.92%

OM growth 3Y-72.52%

OM growth 5Y-32.82%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-19.47%

GM growth 5Y-3.22%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

TSE does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for TSE has been increased compared to 1 year ago.

The number of shares outstanding for TSE has been reduced compared to 5 years ago.

The debt/assets ratio for TSE is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.97, we must say that TSE is in the distress zone and has some risk of bankruptcy.

TSE has a worse Altman-Z score (0.97) than 76.19% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	0.97

ROIC/WACCN/A

WACC7.21%

2.3 Liquidity

TSE has a Current Ratio of 1.50. This is a normal value and indicates that TSE is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 1.50, TSE is doing worse than 67.86% of the companies in the same industry.

TSE has a Quick Ratio of 1.50. This is a bad value and indicates that TSE is not financially healthy enough and could expect problems in meeting its short term obligations.

TSE has a Quick ratio of 0.95. This is in the lower half of the industry: TSE underperforms 67.86% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.5
Quick Ratio	0.95

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

TSE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.64%, which is quite good.

Looking at the last year, TSE shows a decrease in Revenue. The Revenue has decreased by -5.28% in the last year.

Measured over the past years, TSE shows a small growth in Revenue. The Revenue has been growing by 0.81% on average per year.

EPS 1Y (TTM)9.64%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%29.38%

Revenue 1Y (TTM)-5.28%

Revenue growth 3Y-10.05%

Revenue growth 5Y0.81%

Sales Q2Q%-13.19%

3.2 Future

The Earnings Per Share is expected to grow by 20.67% on average over the next years. This is a very strong growth

The Revenue is expected to grow by 4.34% on average over the next years.

EPS Next Y27.34%

EPS Next 2Y24.32%

EPS Next 3Y20.67%

EPS Next 5YN/A

Revenue Next Year-0.36%

Revenue Next 2Y2.01%

Revenue Next 3Y4.34%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

TSE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TSE. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

TSE's Enterprise Value to EBITDA ratio is in line with the industry average.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	13.66

4.3 Compensation for Growth

A more expensive valuation may be justified as TSE's earnings are expected to grow with 20.67% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y24.32%

EPS Next 3Y20.67%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

TSE has a Yearly Dividend Yield of 1.18%. Purely for dividend investing, there may be better candidates out there.

Compared to an average industry Dividend Yield of 3.68, TSE has a dividend in line with its industry peers.

Compared to an average S&P500 Dividend Yield of 2.40, TSE's dividend is way lower than the S&P500 average.

		Industry Rank	Sector Rank
Dividend Yield	1.18%

5.2 History

The dividend of TSE decreases each year by -50.57%.

TSE has been paying a dividend for at least 10 years, so it has a reliable track record.

Dividend Growth(5Y)-50.57%

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

TSE has negative earnings and hence a negative payout ratio. The dividend may be in danger.

DP-0.45%

EPS Next 2Y24.32%

EPS Next 3Y20.67%

More info and screens

Find the best dividend stocks

Show peers with best dividend

TRINSEO PLC

NYSE:TSE (6/18/2025, 8:04:00 PM)

After market: 3.77 0 (0%)

3.77

+0.02 (+0.53%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)05-07 2025-05-07/amc

Earnings (Next)N/A N/A

Inst Owners71.35%

Inst Owner Change1.03%

Ins Owners5.5%

Ins Owner Change24.31%

Market Cap134.40M

Analysts50

Price Target4.39 (16.45%)

Short Float %2.52%

Short Ratio2.57

Dividend

		Industry Rank	Sector Rank
Dividend Yield	1.18%

Yearly Dividend0.05

Dividend Growth(5Y)-50.57%

DP-0.45%

Div Incr Years0

Div Non Decr Years0

Ex-Date04-10 2025-04-10 (0.01)

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-7.45%

Min EPS beat(2)-15.89%

Max EPS beat(2)0.99%

EPS beat(4)1

Avg EPS beat(4)-9.86%

Min EPS beat(4)-15.89%

Max EPS beat(4)0.99%

EPS beat(8)2

Avg EPS beat(8)-68.87%

EPS beat(12)2

Avg EPS beat(12)-54.58%

EPS beat(16)4

Avg EPS beat(16)-41.48%

Revenue beat(2)0

Avg Revenue beat(2)-7.71%

Min Revenue beat(2)-14.85%

Max Revenue beat(2)-0.57%

Revenue beat(4)0

Avg Revenue beat(4)-5.6%

Min Revenue beat(4)-14.85%

Max Revenue beat(4)-0.57%

Revenue beat(8)1

Avg Revenue beat(8)-5.51%

Revenue beat(12)1

Avg Revenue beat(12)-5.88%

Revenue beat(16)3

Avg Revenue beat(16)-4.16%

PT rev (1m)-21.82%

PT rev (3m)-24.56%

EPS NQ rev (1m)-5.35%

EPS NQ rev (3m)-4.31%

EPS NY rev (1m)0%

EPS NY rev (3m)-13.51%

Revenue NQ rev (1m)-6.23%

Revenue NQ rev (3m)-6.23%

Revenue NY rev (1m)-3.66%

Revenue NY rev (3m)-3.66%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.04
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	13.66

EPS(TTM)-7.12

EYN/A

EPS(NY)-3.49

Fwd EYN/A

FCF(TTM)-3.21

FCFYN/A

OCF(TTM)-1.63

OCFYN/A

SpS95.2

BVpS-19.05

TBVpS-37.15

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-13.26%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	7.92%
FCFM	N/A

ROA(3y)-15.93%

ROA(5y)-7.64%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3Y-72.52%

OM growth 5Y-32.82%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-19.47%

GM growth 5Y-3.22%

F-Score4

Asset Turnover1.28

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	12.76
Cap/Depr	27.98%
Cap/Sales	1.66%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.5
Quick Ratio	0.95
Altman-Z	0.97

F-Score4

WACC7.21%

ROIC/WACCN/A

Cap/Depr(3y)41.39%

Cap/Depr(5y)51.15%

Cap/Sales(3y)2.23%

Cap/Sales(5y)2.42%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)9.64%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%29.38%

EPS Next Y27.34%

EPS Next 2Y24.32%

EPS Next 3Y20.67%

EPS Next 5YN/A

Revenue 1Y (TTM)-5.28%

Revenue growth 3Y-10.05%

Revenue growth 5Y0.81%

Sales Q2Q%-13.19%

Revenue Next Year-0.36%

Revenue Next 2Y2.01%

Revenue Next 3Y4.34%

Revenue Next 5YN/A

EBIT growth 1Y77.12%

EBIT growth 3Y-75.28%

EBIT growth 5Y-32.27%

EBIT Next Year793.49%

EBIT Next 3Y136.74%

EBIT Next 5YN/A

FCF growth 1Y-119.35%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-161.98%

OCF growth 3YN/A

OCF growth 5YN/A

TRINSEO PLC (TSE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens